Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Acadia Healthcare Company, Inc. (ACHC) Expected to Post Q2 2017 Earnings of $0.64 Per Share
Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
Acadia Healthcare Company, Inc. (NASDAQ:ACHC) – Equities research analysts at William Blair issued their Q2 2017 earnings per share estimates for Acadia Healthcare in a research report issued on Tuesday. William Blair analyst R. Daniels expects that the company will post earnings per share of $0.64 for the quarter. William Blair currently has a “Outperform” rating on the stock. William Blair also issued estimates for Acadia Healthcare’s Q3 2017 earnings at $0.67 EPS, Q4 2017 earnings at $0.67 EPS, FY2017 earnings at $2.44 EPS, FY2018 earnings at $2.82 EPS and FY2019 earnings at $3.11 EPS.
Several other equities research analysts have also issued reports on ACHC. BidaskClub raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Saturday, June 10th. Cantor Fitzgerald reissued a “hold” rating and issued a $45.00 target price on shares of Acadia Healthcare in a research note on Wednesday, April 26th. Zacks Investment Research raised Acadia Healthcare from a “hold” rating to a “buy” rating and set a $53.00 target price for the company in a research note on Wednesday, June 28th. Jefferies Group LLC reissued a “buy” rating on shares of Acadia Healthcare in a research note on Monday, May 15th. Finally, KeyCorp reissued an “overweight” rating and issued a $51.00 target price on shares of Acadia Healthcare in a research note on Thursday, June 1st. Three investment analysts have rated the stock with a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $57.23.
COPYRIGHT VIOLATION NOTICE: “[[title]]” was first reported by [[site]] and is the sole property of of [[site]]. If you are viewing this news story on another domain, it was illegally copied and reposted in violation of U.S. and international copyright law. The legal version of this news story can be accessed at [[permalink]].
Acadia Healthcare (ACHC) opened at 50.90 on Thursday. The firm has a 50-day moving average price of $47.24 and a 200-day moving average price of $43.11. The firm has a market cap of $4.47 billion, a PE ratio of 295.93 and a beta of 1.14. Acadia Healthcare has a one year low of $32.54 and a one year high of $57.29.
Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Tuesday, April 25th. The company reported $0.46 earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of $0.46. Acadia Healthcare had a return on equity of 8.89% and a net margin of 0.53%. The business had revenue of $679.20 million during the quarter, compared to analysts’ expectations of $691.74 million. During the same quarter in the prior year, the firm earned $0.55 EPS. The business’s revenue for the quarter was up 10.1% compared to the same quarter last year.
In related news, Director Reeve B. Waud sold 50,000 shares of the business’s stock in a transaction dated Wednesday, July 5th. The stock was sold at an average price of $50.04, for a total transaction of $2,502,000.00. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, COO Ronald Morgan Fincher sold 86,483 shares of the business’s stock in a transaction dated Monday, May 1st. The shares were sold at an average price of $44.43, for a total value of $3,842,439.69. Following the transaction, the chief operating officer now owns 137,204 shares in the company, valued at approximately $6,095,973.72. The disclosure for this sale can be found here. In the last three months, insiders sold 968,102 shares of company stock valued at $44,283,109. 11.10% of the stock is currently owned by corporate insiders.
A number of hedge funds and other institutional investors have recently made changes to their positions in ACHC. Emerald Mutual Fund Advisers Trust acquired a new position in shares of Acadia Healthcare during the first quarter worth about $210,000. Paloma Partners Management Co acquired a new position in shares of Acadia Healthcare during the first quarter worth about $217,000. M&T Bank Corp acquired a new position in shares of Acadia Healthcare during the first quarter worth about $230,000. Teacher Retirement System of Texas acquired a new position in shares of Acadia Healthcare during the first quarter worth about $258,000. Finally, Benjamin F. Edwards & Company Inc. increased its position in shares of Acadia Healthcare by 224.2% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 6,290 shares of the company’s stock worth $274,000 after buying an additional 4,350 shares in the last quarter.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.